{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T23:40:05Z","timestamp":1777938005221,"version":"3.51.4"},"reference-count":24,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Scand J Public Health"],"abstract":"<jats:sec>\n                    <jats:title>Aims:<\/jats:title>\n                    <jats:p>Overdose deaths have been increasing in parts of Europe, including Norway, where opioid analgesics have been the leading cause since 2016. This study quantifies the risk of overdose death following exposure to dispensed opioid analgesics, stratified by sex and age, and examines associated causes of death.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Nationwide data from 2010 to 2018 on overdose deaths were obtained from the Norwegian Cause of Death Registry and linked with the Norwegian Prescription Database to identify prior opioid analgesic dispensations. Aggregated prescription data and population figures from Statistics Norway were also used.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>From 2010 to 2018, 42% of individuals who died from an overdose had been dispensed opioid analgesics in the previous year. Among those dispensed strong opioid analgesics, the overdose death rate was low but exceeded the population death rate among men aged 20\u201349 and women aged 20\u201339 years. The rate was higher in men and remained stable over time. Opioids other than heroin or methadone were listed as the cause of death in 62% of cases with prior dispensed opioid analgesics, compared with 24% among those without.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>\n                      <jats:bold>The risk of overdose deaths following exposure to strong opioid analgesics was low but higher than population death rates for men under 50 and women under 40 years. Preventive strategies based on risk markers such as sex, age and opioid analgesic strengths, combined with other known risk markers, can help guide safer prescription of opioid analgesics and reduce overdose death.<\/jats:bold>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/14034948261424666","type":"journal-article","created":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T09:34:32Z","timestamp":1773308072000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Risk and cause of overdose death after exposure to dispensed opioid analgesics"],"prefix":"10.1177","author":[{"given":"Ellen J.","family":"Amundsen","sequence":"first","affiliation":[{"name":"Department of Alcohol, Tobacco and Drugs, Norwegian Institute of Public Health, Oslo, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Svetlana","family":"Skurtveit","sequence":"additional","affiliation":[{"name":"Department of Chronic Diseases, Norwegian Institute of Public Health, Oslo, Norway"},{"name":"Norwegian Centre for Addiction Research (SERAF), University of Oslo, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5337-8619","authenticated-orcid":false,"given":"Ingvild","family":"Odsbu","sequence":"additional","affiliation":[{"name":"Department of Chronic Diseases, Norwegian Institute of Public Health, Oslo, Norway"},{"name":"Norwegian Centre for Addiction Research (SERAF), University of Oslo, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2026,3,12]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"crossref","unstructured":"Pierce M van Amsterdam JK Kalkman GA et al. Is Europe facing an opioid crisis like the United States? An analysis of opioid use and related adverse effects in 19 European countries between 2010 and 2018. Eur Psychiatry 2021; 64:e47. https:\/\/doi.org\/10.1192\/j.eurpsy.2021.2219","DOI":"10.1192\/j.eurpsy.2021.2219"},{"key":"e_1_3_3_3_2","doi-asserted-by":"crossref","unstructured":"Van Amsterdam JV Pierce M van den Brink W. Is Europe Facing an emerging opioid crisis comparable to the U.S.? Ther Drug Monit 2021;43:42-51. https:\/\/doi.org\/10.1097\/FTD.0000000000000789","DOI":"10.1097\/FTD.0000000000000789"},{"key":"e_1_3_3_4_2","doi-asserted-by":"crossref","unstructured":"Krausz RM. Westenberg JN Ziafat K. The opioid overdose crisis as a global health challenge. Curr Opin Psychiatry 2021;34:405-12. https:\/\/doi:10.1097\/YCO.0000000000000712","DOI":"10.1097\/YCO.0000000000000712"},{"key":"e_1_3_3_5_2","doi-asserted-by":"crossref","unstructured":"Gjersing L Amundsen E. Increasing trend in accidental pharmaceutical opioid overdose deaths and diverging overdose death correlates following the opioid prescription policy liberalization in Norway 2010\u20132018. Int J Drug Policy 2022;108:1-8. https:\/\/doi.org\/10.1016\/j.drugpo.2022.103785","DOI":"10.1016\/j.drugpo.2022.103785"},{"key":"e_1_3_3_6_2","unstructured":"Folkehelseinstituttet 2024 a [The Norwegian Institute of Public Health]. Narkotikautl\u00f8ste d\u00f8dsfall 2023 [Overdose deaths 2023]. The Norwegian Cause of Death Registry. https:\/\/www.fhi.no\/le\/rusmidler-og-avhengighet\/narkotikainorge\/konsekvenser-av-narkotikabruk\/narkotikautloste-dodsfall\/ (accessed 20 April 2025)."},{"key":"e_1_3_3_7_2","unstructured":"Folkehelseinstituttet 2024 b [The Norwegian Institute of Public Health]. Tall fra Legemiddelregisteret 2010-2018 [Figures from the Norwegian Prescription Database 2010-2018]. The Norwegian Prescription Database (NorPD). https:\/\/www.fhi.no\/he\/legemiddelregisteret\/ (accessed 20 April 2025)."},{"key":"e_1_3_3_8_2","doi-asserted-by":"crossref","unstructured":"Learney S Peacock A Tran LT et al. All-cause and overdose mortality risk among people prescribed opioids: A systematic review and meta-analysis. Pain Med 2020;21:3700-11. https:\/\/doi.org\/10.1093\/pm\/pnaa214","DOI":"10.1093\/pm\/pnaa214"},{"key":"e_1_3_3_9_2","doi-asserted-by":"crossref","unstructured":"Hamina A Odsbu I Hjellvik V et al. Fatal drug overdoses in individuals treated pharmacologically for chronic pain: A nationwide register-based study. Br J Anaesth 2023;132:86-95. https:\/\/doi.org\/10.1016\/j.bja.2023.10.016","DOI":"10.1016\/j.bja.2023.10.016"},{"key":"e_1_3_3_10_2","doi-asserted-by":"crossref","unstructured":"Abbasi AB Salisbury-Afshar E Berberet C et al. Opioid prescribing patterns prior to fatal opioid overdose. Am J Prev Med 2020;58:250\u201353. https:\/\/doi.org\/10.1016\/j.amepre.2019.09.022","DOI":"10.1016\/j.amepre.2019.09.022"},{"key":"e_1_3_3_11_2","doi-asserted-by":"crossref","unstructured":"Brady JE Giglio R Keyes KM et al. Risk markers for fatal and non-fatal prescription drug overdose: A meta-analysis.\u2009Inj Epidemiol\u20092017;4:24. https:\/\/doi.org\/10.1186\/s40621-017-0118-7","DOI":"10.1186\/s40621-017-0118-7"},{"key":"e_1_3_3_12_2","volume-title":"Resultater fra Global Burden of Diseases, Injuries, and Risk Factors Study 2016 (GBD 2016)","author":"\u00d8verland S","year":"2018","unstructured":"\u00d8verland S, Knudsen AK, Vollset SE, et al. Sykdomsbyrde i Norge 2016. Resultater fra Global Burden of Diseases, Injuries, and Risk Factors Study 2016 (GBD 2016). [Disease burden in Norway 2016. Results from the Global Burden of Diseases, Injuries, and Risk Factors Study 2016 (GBD 2016)]. Report 2018. Bergen\/Oslo: Folkehelseinstituttet, 2018."},{"key":"e_1_3_3_13_2","doi-asserted-by":"crossref","unstructured":"Skurtveit S Odsbu I Gjersing L et al. Individuals dying of overdoses related to pharmaceutical opioids differ from individuals dying of overdoses related to other substances: a population-based register study. Eur Addict Res 2022;28:419-24. https:\/\/doi.org\/10.1159\/000526145","DOI":"10.1159\/000526145"},{"key":"e_1_3_3_14_2","unstructured":"International Statistical Classification of Diseases and Related Health Problems 10th Revision. 2019. https:\/\/icd.who.int\/browse10\/2019\/en (accessed 20 April 2025)."},{"key":"e_1_3_3_15_2","unstructured":"European Union Drugs Agency archive: methods and definitions in EMCDDA Statistical Bulletin. https:\/\/www.euda.europa.eu\/data\/stats2025\/methods\/drd_en (2005 accessed 20 April 2025)."},{"key":"e_1_3_3_16_2","unstructured":"Gjersing L. Narkotikautl\u00f8ste d\u00f8dsfall 2023 \u2013 FHI [Drug induced deaths 2023]. Folkehelseinstituttet [The Norwegian Institute of Public Health] https:\/\/www.fhi.no\/le\/rusmidler-og-avhengighet\/narkotikainorge\/konsekvenser-av-narkotikabruk\/narkotikautloste-dodsfall\/ (2024)"},{"key":"e_1_3_3_17_2","doi-asserted-by":"crossref","unstructured":"Amundsen EJ Odsbu I Skurtveit SO et al. Patterns of filled prescriptions and the association with risk of drug-induced death. A population-based nested case-control register study. J Pharmacoepidemiol Drug Saf 2024;33:e5763. https:\/\/doi.org\/10.1002\/pds.5763","DOI":"10.1002\/pds.5763"},{"key":"e_1_3_3_18_2","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology. ATC classification index with DDDs. https:\/\/atcddd.fhi.no\/atc_ddd_index\/ (2024 accessed 20 April 2025)."},{"key":"e_1_3_3_19_2","unstructured":"MedCalc. MedCalc's free statistical calculators. MedCalc Software Ltd. https:\/\/www.medcalc.org\/en\/calc (accessed 15 August 2024)."},{"key":"e_1_3_3_20_2","article-title":"Moralisme I behandling av rus og psykiske lidelser","author":"Bramness JG","year":"2024","unstructured":"Bramness JG, Lien L. Moralisme I behandling av rus og psykiske lidelser. [Moralism in the treatment of substance abuse and mental disorders]. Aftenposten 31 March 2024. https:\/\/www.aftenposten.no\/meninger\/debatt\/i\/GMzVp9\/moralismen-i-behandlingen-av-rus-og-psykiske-lidelser","journal-title":"Aftenposten"},{"key":"e_1_3_3_21_2","doi-asserted-by":"crossref","unstructured":"Rolova G Skurtveit S Handal M et al. Trends in opioid prescribing in Scandinavian countries from 2010 to 2023: Insights from multi-metric evaluation Br J Clin Pharmacol. Epub ahead of print 28 July 2025. https:\/\/doi.org\/10.1002\/bcp.7017","DOI":"10.1002\/bcp.70177"},{"key":"e_1_3_3_22_2","doi-asserted-by":"crossref","unstructured":"Edvardsen HME Clausen T Bogstrand ST et al. The role of\u2009prescribed opioids in\u2009Norwegian overdose deaths in\u20092005\u20132021. Eur J Clin Pharmacol (2025;81:1633\u201341. https:\/\/doi.org\/10.1007\/s00228-025-03897-5","DOI":"10.1007\/s00228-025-03897-5"},{"key":"e_1_3_3_23_2","doi-asserted-by":"crossref","unstructured":"Amundsen EJ. Drug-related causes of death: Socioeconomic and demographic characteristics of the deceased. Scand J Public Health 2015;43: 571\u20139. https:\/\/doi.org\/10.1177\/1403494815585909","DOI":"10.1177\/1403494815585909"},{"key":"e_1_3_3_24_2","unstructured":"Helsedirektoratet [Norwegian Directorate of Health]. Nasjonal veileder for vanedannende legemidler [nettdokument] [National Guidelines for Addictive Medications]. Oslo: Norwegian Directorate of Health. https:\/\/www.helsedirektoratet.no\/rapporter\/handlingsplan-mot-overdoser\/forvaltning-og-implementering-av-nasjonale-faglige-anbefalinger\/nasjonal-veileder-for-vanedannende-legemidler (2021 accessed 21 May 2024)."},{"key":"e_1_3_3_25_2","doi-asserted-by":"crossref","unstructured":"R\u00e6der J. Hva er riktig forbruk av opioder? [What is the correct use of opioids?] Tidsskrift for den Norske Legeforening https:\/\/doi.org\/10.4045\/tidsskr.20.0647 (2020);140.","DOI":"10.4045\/tidsskr.20.0647"}],"container-title":["Scandinavian Journal of Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/14034948261424666","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/14034948261424666","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/14034948261424666","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T04:20:31Z","timestamp":1777695631000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/14034948261424666"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,12]]},"references-count":24,"alternative-id":["10.1177\/14034948261424666"],"URL":"https:\/\/doi.org\/10.1177\/14034948261424666","relation":{},"ISSN":["1403-4948","1651-1905"],"issn-type":[{"value":"1403-4948","type":"print"},{"value":"1651-1905","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,12]]},"article-number":"14034948261424666"}}